S Ichikawa

Summary

Affiliation: Indiana University
Country: USA

Publications

  1. ncbi A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells
    Shoji Ichikawa
    Department of Medicine, Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Bone Miner Res 27:453-60. 2012
  2. ncbi Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis
    Shoji Ichikawa
    Department of Medicine, Division of Endocrinology and Metabolism, Indiana University School of Medicine, 541 North Clinical Drive, CL 459, Indianapolis, Indiana 46202, USA
    Endocrinology 152:4504-13. 2011
  3. ncbi Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations
    Shoji Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Am J Med Genet A 152:896-903. 2010
  4. ncbi Replication of previous genome-wide association studies of bone mineral density in premenopausal American women
    Shoji Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    J Bone Miner Res 25:1821-9. 2010
  5. ncbi A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
    S Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Musculoskelet Neuronal Interact 7:318-9. 2007
  6. ncbi Association studies of ALOX5 and bone mineral density in healthy adults
    T Foroud
    Indiana University School of Medicine, Health Information and Translational Sciences Building, Indianapolis, IN 46202 3002, USA
    Osteoporos Int 19:637-43. 2008
  7. ncbi Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect bone mineral density in white men or women
    S Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    Osteoporos Int 17:587-92. 2006
  8. ncbi Assignment1 of a UDP-glucose:ceramide glucosyltransferase gene (Ugcg) to mouse chromosome band 4B3 by in situ hybridization
    S Ichikawa
    Laboratory for Cellular Glycobiology, Frontier Research Program, The Institute of Physical and Chemical Research (RIKEN, Saitama (Japan
    Cytogenet Cell Genet 83:14-5. 1998
  9. ncbi Assignment of a UDP-glucose:ceramide glucosyltransferase gene (UGCG) to human chromosome band 9q31 by in situ hybridization
    S Ichikawa
    Laboratory for Cellular Glycobiology, Frontier Research Program, The Institute of Chemical and Physical Research (RIKEN, Saitama, Japan
    Cytogenet Cell Genet 79:233-4. 1997
  10. ncbi beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma ce
    J K Hidari
    Laboratory for Glyco Cell Biology, Institute of Physical and Chemical Research RIKEN, Saitama, Japan
    Biochem J 303:957-65. 1994

Detail Information

Publications11

  1. ncbi A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells
    Shoji Ichikawa
    Department of Medicine, Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Bone Miner Res 27:453-60. 2012
    ..These data suggest that Phex mutations alter the responsiveness of bone cells to extracellular phosphate concentrations and may create a lower set point for "normal" phosphate levels...
  2. ncbi Dietary phosphate restriction normalizes biochemical and skeletal abnormalities in a murine model of tumoral calcinosis
    Shoji Ichikawa
    Department of Medicine, Division of Endocrinology and Metabolism, Indiana University School of Medicine, 541 North Clinical Drive, CL 459, Indianapolis, Indiana 46202, USA
    Endocrinology 152:4504-13. 2011
    ..In conclusion, dietary phosphate restriction normalizes biochemical and skeletal phenotypes of Galnt3 knockout mice and, thus, can be an effective therapy for tumoral calcinosis...
  3. ncbi Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations
    Shoji Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA
    Am J Med Genet A 152:896-903. 2010
    ..Therefore, tumoral calcinosis and hyperostosis-hyperphosphatemia syndrome represent a continuous spectrum of the same disease caused by increased phosphate levels, rather than two distinct disorders...
  4. ncbi Replication of previous genome-wide association studies of bone mineral density in premenopausal American women
    Shoji Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    J Bone Miner Res 25:1821-9. 2010
    ....
  5. ncbi A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
    S Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
    J Musculoskelet Neuronal Interact 7:318-9. 2007
  6. ncbi Association studies of ALOX5 and bone mineral density in healthy adults
    T Foroud
    Indiana University School of Medicine, Health Information and Translational Sciences Building, Indianapolis, IN 46202 3002, USA
    Osteoporos Int 19:637-43. 2008
    ..We tested this hypothesis in a sample of healthy men and women and did not find consistent evidence for an association between variation in this gene and either lumbar spine or femoral neck BMD...
  7. ncbi Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect bone mineral density in white men or women
    S Ichikawa
    Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    Osteoporos Int 17:587-92. 2006
    ..Recently, bone morphogenetic protein 2 (BMP2) was reported as a susceptibility gene for osteoporotic fractures and low BMD in Icelandic and Danish populations...
  8. ncbi Assignment1 of a UDP-glucose:ceramide glucosyltransferase gene (Ugcg) to mouse chromosome band 4B3 by in situ hybridization
    S Ichikawa
    Laboratory for Cellular Glycobiology, Frontier Research Program, The Institute of Physical and Chemical Research (RIKEN, Saitama (Japan
    Cytogenet Cell Genet 83:14-5. 1998
  9. ncbi Assignment of a UDP-glucose:ceramide glucosyltransferase gene (UGCG) to human chromosome band 9q31 by in situ hybridization
    S Ichikawa
    Laboratory for Cellular Glycobiology, Frontier Research Program, The Institute of Chemical and Physical Research (RIKEN, Saitama, Japan
    Cytogenet Cell Genet 79:233-4. 1997
  10. ncbi beta 1-4N-acetylgalactosaminyltransferase can synthesize both asialoglycosphingolipid GM2 and glycosphingolipid GM2 in vitro and in vivo: isolation and characterization of a beta 1-4N-acetylgalactosaminyltransferase cDNA clone from rat ascites hepatoma ce
    J K Hidari
    Laboratory for Glyco Cell Biology, Institute of Physical and Chemical Research RIKEN, Saitama, Japan
    Biochem J 303:957-65. 1994
    ..l.c.-immunostaining method. These observations also supported our conclusion that the single GalNAc-T synthesizes asialo-GM2, GM2 and GD2 in vivo...
  11. ncbi Localization of the ribosome-releasing factor gene in the Escherichia coli chromosome
    S Ichikawa
    Department of Microbiology, School of Medicine, University of Pennsylvania, Philadelphia 19104
    J Bacteriol 171:3689-95. 1989
    ..The exact location of the translational initiation site of the RRF gene was determined to be 1.1 kilobases downstream from the translational termination site of tsf. The RRF gene is designated frr...